These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4961002)

  • 1. Kasugamycin in pseudomonas infections of the urinary tract.
    Ichikawa T; Umezawa H
    J Urol; 1967 May; 97(5):917-25. PubMed ID: 4961002
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences in the use of Kasugamycin in urology].
    Shigematsu S; Eto K; Mukoda M; Higuchi M
    J Antibiot B; 1967 Jun; 20(3):194-6. PubMed ID: 4965585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of kasugamycin in urinary tract infection, especially against Pseudomonas aeruginosa].
    Tada S; Hakamada T; Mori O; Yamazaki Y
    Hinyokika Kiyo; 1968 Jan; 14(1):50-6. PubMed ID: 4971183
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment.
    Westenfelder SR; Welling G; Madsen PO
    Infection; 1974; 2(2):76-9. PubMed ID: 4842961
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical report of treatment of urinary tract infections with lividomycin].
    Ichikawa T; Nakano I; Hirokawa I; Nakamura M
    Jpn J Antibiot; 1972 Dec; 25(6):389-95. PubMed ID: 4579558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of Kasugamycin for urinary tract infections due to Pseudomonas aeruginosa].
    Ishigami J; Fukuda Y; Hara S
    J Antibiot B; 1967 Apr; 20(2):83-4. PubMed ID: 5299159
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of various Pseudomonas aeruginosa infections with Kasugamycin].
    Donomae I; Tachibana T; Suzuki I; Matsunaga T; Kobayashi Y
    J Antibiot B; 1967 Jun; 20(3):175-8. PubMed ID: 4965580
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with Kasugamycin in Pseudomonas aeruginosa infections in dermatology].
    Hiramoto M; Hiramatsu Y; Ogawa Y; Ogino A; Horio T
    J Antibiot B; 1967 Oct; 20(5):364-7. PubMed ID: 4967846
    [No Abstract]   [Full Text] [Related]  

  • 9. Kasugamycin treatment of Pseudomonas infection of the urinary tract.
    Ichikawa T
    Antimicrob Agents Chemother (Bethesda); 1965; 5():758-64. PubMed ID: 5883495
    [No Abstract]   [Full Text] [Related]  

  • 10. Tobramycin treatment of pseudomonas aeruginosa infections in cystic fibrosis.
    Hoff GE; Schiotz PO; Paulsen J
    Scand J Infect Dis; 1974; 6(4):333-7. PubMed ID: 4217466
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the usefulness of a novel injectable cephalosporin, E1040, and ceftazidime for management of complicated urinary tract infections caused by Pseudomonas aeruginosa and Proteus mirabilis by using the rat urolithiasis model.
    Satoh M; Munakata K; Takeuchi H; Yoshida O
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1580-3. PubMed ID: 1510458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences in the use of Kasugamycin for 3rd degree burns infected by Pseudomonas aeruginosa].
    Nakai Y; Asada Y; Sofue M; Shiozaki H
    J Antibiot B; 1967 Jun; 20(3):191-3. PubMed ID: 4965584
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of lividomycin in urinary tract infections].
    Tokito T; Shigematsu S; Eto K
    Jpn J Antibiot; 1972 Dec; 25(6):432-5. PubMed ID: 4579564
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic effects of lividomycin in urinary tract infections caused by Pseudomonas aeruginosa].
    Tanaka E; Nakazawa S; Sato H
    Jpn J Antibiot; 1972 Dec; 25(6):446-51. PubMed ID: 4198944
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with lividomycin in urinary tract infections].
    Nijima T; Fujita Y; Kondo K; Amano M
    Jpn J Antibiot; 1972 Dec; 25(6):427-31. PubMed ID: 4579563
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of carbenicillin in treatment of infections of the urinary tract.
    Turck M; Silverblatt F; Clark H; Holmes K
    J Infect Dis; 1970 Sep; 122():Suppl:S29-33. PubMed ID: 4918331
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.
    Saavedra S; Ramírez-Ronda CH; Nevárez M
    Eur J Clin Microbiol; 1986 Apr; 5(2):255-7. PubMed ID: 2941296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pseudomonas aeruginosa infections in the service of infectious diseases at CHU YO, Burkina Faso: about two cases].
    Mamoudou S; Lassina D; Fla K
    Pan Afr Med J; 2015; 21():78. PubMed ID: 26491521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some newer antimicrobial agents with antipseudomonal activity.
    Pritchard RC
    Med J Aust; 1989 Jun; 150(12):708-11, 714-5. PubMed ID: 2543891
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of using aminoglycoside antibiotics in septicemia and urinary tract infections in newborn infants].
    Sentsova TB; Bombardirova EP; Mamedkulieva DT; Bekmukhambetova ER
    Antibiot Khimioter; 1990 Oct; 35(10):50-2. PubMed ID: 2126174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.